Ocugen (OCGN) Change in Accured Expenses (2014 - 2026)
Ocugen posted quarterly Change in Accured Expenses of -$5.4 million for Q1 2026, down 65.18% year-on-year from -$15.5 million in Q1 2025, and down 547.6% on a QoQ basis from $1.2 million in Q4 2025.
Ocugen (OCGN) has 13 years of Change in Accured Expenses data on file, last reported at -$5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 65.18% year-over-year to -$5.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 48.98% YoY), and the FY2025 full-year result was $3.3 million, down 19.97% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$5.4 million, down from $1.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.9 million in Q3 2022 and bottomed at -$5.4 million in Q1 2026.
- The 5-year median for Change in Accured Expenses is $1.2 million (2025), against an average of -$47411.8.
- The widest annual swing landed in 2022, when Change in Accured Expenses soared 380.45%; it then tumbled 3889.31% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $2.8 million in 2022, then sank by 170.5% to -$1.9 million in 2023, then jumped by 207.62% to $2.1 million in 2024, then sank by 42.27% to $1.2 million in 2025, then tumbled by 547.6% to -$5.4 million in 2026.
- The last three Change in Accured Expenses figures came in at -$5.4 million (Q1 2026), $1.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.40 Mn |
| Mar 31, 2026 | -5.40 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | -3.27 Mn |
| Mar 31, 2025 | -3.27 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Dec 31, 2023 | -1.94 Mn |
| Dec 31, 2023 | -1.94 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -4.09 Mn |
| Jun 30, 2023 | -4.09 Mn |
| Mar 31, 2023 | -4.96 Mn |
| Mar 31, 2023 | -4.96 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 2.71 Mn |
| Mar 31, 2022 | 131,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 573,000.00 |
| Dec 31, 2021 | 573,000.00 |
| Sep 30, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 405,000.00 |
| Mar 31, 2021 | 405,000.00 |
| Dec 31, 2020 | 592,000.00 |
| Dec 31, 2020 | 592,000.00 |
| Sep 30, 2020 | 87,000.00 |
| Sep 30, 2020 | 87,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Mar 31, 2020 | -1.23 Mn |
| Mar 31, 2020 | -1.23 Mn |
| Dec 31, 2019 | -3.67 Mn |
| Dec 31, 2019 | -3.67 Mn |
| Sep 30, 2019 | 1.39 Mn |
| Sep 30, 2019 | 1.39 Mn |
| Jun 30, 2019 | -1.07 Mn |
| Jun 30, 2019 | -1.07 Mn |
| Mar 31, 2019 | 1.72 Mn |
| Mar 31, 2019 | 1.72 Mn |
| Dec 31, 2018 | 2.22 Mn |
| Dec 31, 2018 | 2.22 Mn |
| Sep 30, 2018 | 2.48 Mn |
| Sep 30, 2018 | 2.48 Mn |
| Jun 30, 2018 | 538,000.00 |
| Jun 30, 2018 | 538,000.00 |
| Mar 31, 2018 | -1.61 Mn |
| Mar 31, 2018 | -1.61 Mn |
| Dec 31, 2017 | 1.10 Mn |
| Dec 31, 2017 | 1.10 Mn |
| Sep 30, 2017 | 125,000.00 |
| Sep 30, 2017 | 125,000.00 |
| Jun 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 400,000.00 |
| Mar 31, 2017 | -1.10 Mn |
| Mar 31, 2017 | -1.10 Mn |
| Dec 31, 2016 | 613,000.00 |
| Dec 31, 2016 | 613,000.00 |
| Sep 30, 2016 | -702,000.00 |
| Sep 30, 2016 | -702,000.00 |
| Jun 30, 2016 | 1.21 Mn |
| Jun 30, 2016 | 1.21 Mn |
| Mar 31, 2016 | -463,000.00 |
| Mar 31, 2016 | -463,000.00 |
| Dec 31, 2015 | -772,000.00 |
| Dec 31, 2015 | -772,000.00 |
| Sep 30, 2015 | 3.34 Mn |
| Sep 30, 2015 | 3.34 Mn |
| Jun 30, 2015 | -1.34 Mn |
| Jun 30, 2015 | -1.34 Mn |
| Mar 31, 2015 | 317,000.00 |
| Mar 31, 2015 | 317,000.00 |
| Dec 31, 2014 | 54,000.00 |
| Dec 31, 2014 | 54,000.00 |
| Sep 30, 2014 | -47,000.00 |
| Sep 30, 2014 | -47,000.00 |
| Jun 30, 2014 | 879,000.00 |
| Jun 30, 2014 | 879,000.00 |
| Mar 31, 2014 | -238,000.00 |
| Mar 31, 2014 | -238,000.00 |